Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) EBITDA Margin (2020)

Historic EBITDA Margin for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to 11700.0%.

  • Design Therapeutics' EBITDA Margin changed N/A to 11700.0% in Q4 2020 from the same period last year, while for Dec 2020 it was 3685.84%, marking a year-over-year change of. This contributed to the annual value of 3685.84% for FY2020, which is N/A changed from last year.
  • Design Therapeutics' EBITDA Margin amounted to 11700.0% in Q4 2020.
  • In the past 5 years, Design Therapeutics' EBITDA Margin ranged from a high of 438.73% in Q1 2020 and a low of 11915.0% during Q3 2020